Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mihael Varosanec

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Radiology|July 26, 2023
Confounder-adjusted MRI-based predictors of multiple sclerosis disabilityYujin Kim, Mihael Varosanec, Peter Kosa, et al.
NPJ Digital Medicine|February 25, 2021
Smartphone-based symbol-digit modalities test reliably captures brain damage in multiple sclerosisLinh Pham, Thomas Harris, Mihael Varosanec, et al.
Frontiers in Radiology|July 26, 2023
Machine learning-optimized Combinatorial MRI scale (COMRISv2) correlates highly with cognitive and physical disability scales in Multiple Sclerosis patientsErin Kelly, Mihael Varosanec, Peter Kosa, et al.
Nature Communications|December 12, 2022
Molecular models of multiple sclerosis severity identify heterogeneity of pathogenic mechanismsPeter Kosa, Christopher Barbour, Mihael Varosanec, et al.
JCI Insight|June 23, 2022
Enhancing the clinical value of serum neurofilament light chain measurementPeter Kosa, Ruturaj Masvekar, Mika Komori, et al.
Nature Communications|December 3, 2025
Longitudinal proteomic profiling of cerebrospinal fluid in untreated multiple sclerosis defines evolving disease biologyPeter Kosa, Shinji Ashida, Keith Lumbard, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Radiology|July 26, 2023
Confounder-adjusted MRI-based predictors of multiple sclerosis disabilityYujin Kim, Mihael Varosanec, Peter Kosa, et al.
NPJ Digital Medicine|February 25, 2021
Smartphone-based symbol-digit modalities test reliably captures brain damage in multiple sclerosisLinh Pham, Thomas Harris, Mihael Varosanec, et al.
Frontiers in Radiology|July 26, 2023
Machine learning-optimized Combinatorial MRI scale (COMRISv2) correlates highly with cognitive and physical disability scales in Multiple Sclerosis patientsErin Kelly, Mihael Varosanec, Peter Kosa, et al.
Nature Communications|December 12, 2022
Molecular models of multiple sclerosis severity identify heterogeneity of pathogenic mechanismsPeter Kosa, Christopher Barbour, Mihael Varosanec, et al.
JCI Insight|June 23, 2022
Enhancing the clinical value of serum neurofilament light chain measurementPeter Kosa, Ruturaj Masvekar, Mika Komori, et al.
Nature Communications|December 3, 2025
Longitudinal proteomic profiling of cerebrospinal fluid in untreated multiple sclerosis defines evolving disease biologyPeter Kosa, Shinji Ashida, Keith Lumbard, et al.
Pageof 1